Indonesia to keep prescribing two malaria drugs for COVID-19 despite bans in Europe - (This is Money via NewsPoints Desk)

  • A spokesman for Indonesia's COVID-19 taskforce said the country will continue to prescribe two anti-malaria drugs for coronavirus patients but monitor their use closely, as reported in This is Money.

  • The World Health Organization (WHO) announced this week it was temporarily halting its global Solidarity Trial, which was testing hydroxychloroquine in more than 30 countries, including Indonesia.

  • Indonesia has since late March recommended that chloroquine and its derivative, hydroxychloroquine, be widely administered, including to COVID-19 patients with moderate-to-severe symptoms.

  • In an advisory sent by the WHO to Indonesia's health ministry, the global health body said use of the drugs should be suspended "for treating any COVID-19 patients outside the trial."

  • Wiku Adismasmito, from Indonesia's COVID-19 national taskforce, said Indonesia would comply with the advice in relation to the trial, but continue general use under strict monitoring.

  • He said Indonesia would wait for further advice from the WHO in regard to the safety of the drugs, expected in mid-June.

To read more NewsPoints articles, click here.